MS. YI-SHUANG YANG MD
Prescription History 1093787921
Ophthalmology in Anderson, IN
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MS. YI-SHUANG YANG MD, an active Ophthalmology specialist practicing in Anderson, IN. Our medical registry currently tracks 14 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 2,787 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 1,702 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other IN PrescribersVs. IN Avg |
|---|---|---|---|
| Latanoprost | 1,702 | $32.20 | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 1,702 Medicare prescriptions for Latanoprost, about 14 times the volume of the typical Indiana prescriber of this medication (121). Medicare paid an average of $32.20 per fill, versus $23.86 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 4,431 30-Day Fills standardized to 30-day supplies 132,395 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 313 | $58.18 | ▲ More than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 313 Medicare prescriptions for Dorzolamide-Timolol, about 4.7 times the volume of the typical Indiana prescriber of this medication (66). Medicare paid an average of $58.18 per fill, versus $32.44 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 785.1 30-Day Fills standardized to 30-day supplies 23,469 Days of Medication total across all patients in 2023 | |||
| ErythromycinErythromycin Base | 169 | $10.86▼ below IN avg | ▲ More than typical |
About Erythromycin: Erythromycin is used to treat a wide variety of bacterial infections. Show more ▾ It may also be used to prevent certain bacterial infections. Erythromycin is known as a macrolide antibiotic. It works by stopping the growth of bacteria. This antibiotic treats or prevents only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. In 2023, this provider wrote 169 Medicare prescriptions for Erythromycin, about 4.2 times the volume of the typical Indiana prescriber of this medication (40). Medicare paid an average of $10.86 per fill, versus $26.52 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 174.2 30-Day Fills standardized to 30-day supplies 2,449 Days of Medication total across all patients in 2023 | |||
| Ofloxacin | 135 | $14.17▼ below IN avg | ▲ More than typical |
About Ofloxacin: This medication is used to treat eye infections. Show more ▾ Ofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. In 2023, this provider wrote 135 Medicare prescriptions for Ofloxacin, about 2.5 times the volume of the typical Indiana prescriber of this medication (55). Medicare paid an average of $14.17 per fill, versus $21.68 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 142.3 30-Day Fills standardized to 30-day supplies 3,381 Days of Medication total across all patients in 2023 | |||
| MoxifloxacinMoxifloxacin Hcl | 128 | $47.91 | ▲ More than typical |
About Moxifloxacin: This medication is a quinolone antibiotic used for eye infections. Show more ▾ A fluoroquinolone that acts as an inhibitor of DNA TOPOISOMERASE II and is used as a broad-spectrum antibacterial agent. In 2023, this provider wrote 128 Medicare prescriptions for Moxifloxacin, about 2 times the volume of the typical Indiana prescriber of this medication (64). Medicare paid an average of $47.91 per fill, versus $34.41 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 130 30-Day Fills standardized to 30-day supplies 2,762 Days of Medication total across all patients in 2023 | |||
| Prednisolone Acetate | 90 | $50.98 | ≈ Typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 90 Medicare prescriptions for Prednisolone Acetate, about the same volume as the typical Indiana prescriber of this medication (87). Medicare paid an average of $50.98 per fill, versus $49.69 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 131.5 30-Day Fills standardized to 30-day supplies 3,514 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 63 | $68.83 | ▲ More than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 63 Medicare prescriptions for Brimonidine Tartrate, about 1.3 times the volume of the typical Indiana prescriber of this medication (50). Medicare paid an average of $68.83 per fill, versus $40.24 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 158.3 30-Day Fills standardized to 30-day supplies 4,740 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 62 | $606.03 | ▲ More than typical |
About Brimonidine Tartrate-Timolol: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 62 Medicare prescriptions for Brimonidine Tartrate-Timolol, about 3.1 times the volume of the typical Indiana prescriber of this medication (20). Medicare paid an average of $606.03 per fill, versus $287.31 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 154.5 30-Day Fills standardized to 30-day supplies 4,554 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 29 | $106.16▼ below IN avg | ▲ More than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 29 Medicare prescriptions for Timolol Maleate, about 2.6 times the volume of the typical Indiana prescriber of this medication (11). Medicare paid an average of $106.16 per fill, versus $561.10 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 77.5 30-Day Fills standardized to 30-day supplies 2,325 Days of Medication total across all patients in 2023 | |||
| LumiganBimatoprost | 28 | $733.84 | ▼ Less than typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 28 Medicare prescriptions for Lumigan, about half the volume of the typical Indiana prescriber of this medication (52). Medicare paid an average of $733.84 per fill, versus $479.94 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 79.7 30-Day Fills standardized to 30-day supplies 2,390 Days of Medication total across all patients in 2023 | |||
| Alphagan PBrimonidine Tartrate | 21 | $531.46 | ▼ Less than typical |
About Alphagan P: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 21 Medicare prescriptions for Alphagan P, about 72% of the volume of the typical Indiana prescriber of this medication (29). Medicare paid an average of $531.46 per fill, versus $420.94 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 45.7 30-Day Fills standardized to 30-day supplies 1,335 Days of Medication total across all patients in 2023 | |||
| Loteprednol Etabonate | 19 | $160.18▼ below IN avg | ≈ Typical |
About Loteprednol Etabonate: This medication is used to temporarily relieve seasonal allergy symptoms of the eyes such as swelling, redness, and itching. Show more ▾ Loteprednol belongs to a class of drugs known as corticosteroids. An androstadiene derivative corticosteroid that is used as an ANTI-ALLERGIC AGENT for the treatment of inflammatory and allergic eye conditions. In 2023, this provider wrote 19 Medicare prescriptions for Loteprednol Etabonate, about the same volume as the typical Indiana prescriber of this medication (19). Medicare paid an average of $160.18 per fill, versus $208.68 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 21.9 30-Day Fills standardized to 30-day supplies 512 Days of Medication total across all patients in 2023 | |||
| Bacitracin | 14 | $80.92 | – No State Data |
About Bacitracin: This medication is an antibiotic used to treat certain bacterial eye infections. Show more ▾ It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A complex of cyclic peptide antibiotics produced by the Tracy-I strain of Bacillus subtilis. The commercial preparation is a mixture of at least nine bacitracins with bacitracin A as the major constituent. It is used topically to treat open infections such as infected eczema and infected dermal ulcers. (From Goodman and Gilman, The Pharmacological Basis of Therapeutics, 8th ed, p1140) In 2023, this provider wrote 14 Medicare prescriptions for Bacitracin. Medicare paid an average of $80.92 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $80.92 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15.3 30-Day Fills standardized to 30-day supplies 207 Days of Medication total across all patients in 2023 | |||
| Travoprost | 14 | $337.58 | ▼ Less than typical |
About Travoprost: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 14 Medicare prescriptions for Travoprost, about half the volume of the typical Indiana prescriber of this medication (31). Medicare paid an average of $337.58 per fill, versus $238.69 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 32.3 30-Day Fills standardized to 30-day supplies 959 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for MS. YI-SHUANG YANG MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ophthalmology prescribing approach at this Anderson, IN practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among IN prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
